These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Does the use in animals of antimicrobial agents, including glycopeptide antibiotics, influence the efficacy of antimicrobial therapy in humans? Donnelly JP; Voss A; Witte W; Murray BE J Antimicrob Chemother; 1996 Feb; 37(2):389-92. PubMed ID: 8707753 [No Abstract] [Full Text] [Related]
7. [Resistance to glycopeptide antibiotics. New horizons and problems]. Egorov AM; Sazykin IuO Antibiot Khimioter; 2001; 46(6):3-5. PubMed ID: 11573322 [No Abstract] [Full Text] [Related]
8. Glycopeptide-resistant enterococci: a decade of experience. Woodford N J Med Microbiol; 1998 Oct; 47(10):849-62. PubMed ID: 9788808 [TBL] [Abstract][Full Text] [Related]
9. Anti-infectious activity of non-antibiotic drugs and their interactions with antibiotics. Neuman M G Ital Chemioter; 1991; 38(1-3):35-7. PubMed ID: 1365603 [No Abstract] [Full Text] [Related]
11. Clinical relevance of increasing glycopeptide MICs against Staphylococcus aureus. Gould IM Int J Antimicrob Agents; 2008 Apr; 31 Suppl 2():1-9. PubMed ID: 18485997 [TBL] [Abstract][Full Text] [Related]
12. [Molecular and epidemiologic aspects of the resistance to antibiotics: example of glycopeptides on enterococci]. Courvalin P C R Seances Soc Biol Fil; 1996; 190(4):467-9. PubMed ID: 8952897 [TBL] [Abstract][Full Text] [Related]